https://www.selleckchem.com/pr....oducts/netarsudil-ar
Revision knee replacement (KR) is both challenging for the surgical team and expensive for the healthcare provider. Limited high quality evidence is available to guide decision-making. To provide guidelines for surgeons and units delivering revision KR services. A formal consensus process was followed by BASK's Revision Knee Working Group, which included surgeons from England, Wales, Scotland and Northern Ireland. This was supported by analysis of National Joint Registry data. There are a large number of surgeons operating a